JPWO2021195503A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021195503A5 JPWO2021195503A5 JP2022558271A JP2022558271A JPWO2021195503A5 JP WO2021195503 A5 JPWO2021195503 A5 JP WO2021195503A5 JP 2022558271 A JP2022558271 A JP 2022558271A JP 2022558271 A JP2022558271 A JP 2022558271A JP WO2021195503 A5 JPWO2021195503 A5 JP WO2021195503A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- cancer
- cell
- antigen
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025144528A JP2025172113A (ja) | 2020-03-27 | 2025-09-01 | Ｔ細胞受容体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063000800P | 2020-03-27 | 2020-03-27 | |
| US63/000,800 | 2020-03-27 | ||
| PCT/US2021/024370 WO2021195503A1 (en) | 2020-03-27 | 2021-03-26 | T cell receptors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025144528A Division JP2025172113A (ja) | 2020-03-27 | 2025-09-01 | Ｔ細胞受容体 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023519868A JP2023519868A (ja) | 2023-05-15 |
| JPWO2021195503A5 true JPWO2021195503A5 (https=) | 2024-04-05 |
| JP2023519868A5 JP2023519868A5 (https=) | 2024-04-05 |
| JP7738007B2 JP7738007B2 (ja) | 2025-09-11 |
Family
ID=77890524
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022558271A Active JP7738007B2 (ja) | 2020-03-27 | 2021-03-26 | Ｔ細胞受容体 |
| JP2025144528A Pending JP2025172113A (ja) | 2020-03-27 | 2025-09-01 | Ｔ細胞受容体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025144528A Pending JP2025172113A (ja) | 2020-03-27 | 2025-09-01 | Ｔ細胞受容体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230124640A1 (https=) |
| EP (1) | EP4126924A4 (https=) |
| JP (2) | JP7738007B2 (https=) |
| KR (1) | KR20220160040A (https=) |
| CN (1) | CN115485294A (https=) |
| AU (1) | AU2021244594A1 (https=) |
| BR (1) | BR112022019380A2 (https=) |
| CA (1) | CA3177181A1 (https=) |
| IL (1) | IL296827A (https=) |
| MX (1) | MX2022012062A (https=) |
| WO (1) | WO2021195503A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3225252A1 (en) | 2021-07-14 | 2023-01-19 | Jordan JARJOUR | Engineered t cell receptors fused to binding domains from antibodies |
| CN119546328A (zh) | 2022-04-08 | 2025-02-28 | 再生元制药公司 | 多部分受体和信号传导复合物 |
| CN117003855B (zh) * | 2023-09-20 | 2024-02-23 | 广州市老人院 | 一种t细胞受体及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8361794B2 (en) * | 2004-06-29 | 2013-01-29 | Immunocore Limited | Cells expressing a modified T cell receptor |
| LT3424947T (lt) * | 2011-10-28 | 2021-03-10 | Regeneron Pharmaceuticals, Inc. | Genetiškai modifikuotos t ląstelių receptorių pelės |
| CN102876715B (zh) | 2012-09-05 | 2014-07-23 | 南方医科大学 | 一种用于结核/hiv共感染基因治疗的逆转录病毒载体及其应用 |
| CN102911267B (zh) | 2012-09-19 | 2014-04-02 | 南方医科大学 | 一种结核/hiv抗原肽双特异性tcr、其重组逆转录病毒载体与应用 |
| EP3472208B9 (en) | 2016-06-17 | 2023-10-04 | Medigene Immunotherapies GmbH | T cell receptors and uses thereof |
| CN110352068A (zh) * | 2016-12-02 | 2019-10-18 | 南加利福尼亚大学 | 合成的免疫受体及其使用方法 |
| BR112020006643A2 (pt) * | 2017-10-03 | 2020-09-24 | Juno Therapeutics Inc | moléculas de ligação específica ao hpv |
| EP3714941A1 (en) | 2019-03-27 | 2020-09-30 | Medigene Immunotherapies GmbH | Mage-a4 tcrs |
| KR20220030933A (ko) | 2019-05-08 | 2022-03-11 | 메디진 이뮤노테라피스 게엠바하 | 조작된 t 세포 |
| CA3225252A1 (en) * | 2021-07-14 | 2023-01-19 | Jordan JARJOUR | Engineered t cell receptors fused to binding domains from antibodies |
-
2021
- 2021-03-26 AU AU2021244594A patent/AU2021244594A1/en active Pending
- 2021-03-26 CN CN202180032592.3A patent/CN115485294A/zh active Pending
- 2021-03-26 MX MX2022012062A patent/MX2022012062A/es unknown
- 2021-03-26 EP EP21775262.5A patent/EP4126924A4/en active Pending
- 2021-03-26 CA CA3177181A patent/CA3177181A1/en active Pending
- 2021-03-26 IL IL296827A patent/IL296827A/en unknown
- 2021-03-26 US US17/914,483 patent/US20230124640A1/en active Pending
- 2021-03-26 WO PCT/US2021/024370 patent/WO2021195503A1/en not_active Ceased
- 2021-03-26 JP JP2022558271A patent/JP7738007B2/ja active Active
- 2021-03-26 KR KR1020227036819A patent/KR20220160040A/ko active Pending
- 2021-03-26 BR BR112022019380A patent/BR112022019380A2/pt unknown
-
2025
- 2025-09-01 JP JP2025144528A patent/JP2025172113A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jin et al. | Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model | |
| Maheswaran et al. | Intracellular association of the protein product of the c-myc oncogene with the TATA-binding protein | |
| CN113527521B (zh) | 一种抗b7h3嵌合抗原受体及其应用 | |
| Ghiara et al. | Crystal structure of the principal neutralization site of HIV-1 | |
| Gannon et al. | Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. | |
| US6495347B1 (en) | Induction of a Th1-like response in vitro | |
| JP2019535275A5 (https=) | ||
| EP2440575B1 (en) | Identification, optimization and use of shared hla-b*0702 epitopes for immunotherapy | |
| Kannan et al. | Macrocyclization of an all-d linear α-helical peptide imparts cellular permeability | |
| CN110072889A (zh) | 抗程序性细胞死亡配体1(pd-l1)的抗体及其用途 | |
| EP1087993B1 (en) | Fas peptides and antibodies for modulating apoptosis | |
| JPWO2021195503A5 (https=) | ||
| Poljak et al. | Studies on the three-dimensional structure of immunoglobulins | |
| CN110423757A (zh) | 一种工程化核酸、t细胞及其应用和产生方法 | |
| WO2022124282A1 (ja) | Ｐｒａｍｅ結合性分子 | |
| AU776832B2 (en) | Computational design methods for making molecular mimetics | |
| JP2019518713A5 (https=) | ||
| JPH07508749A (ja) | 腫瘍放出粒子（ｔｌｐ）複合体の抗原性領域とそれらに対する抗体 | |
| JPWO2023288267A5 (https=) | ||
| JPWO2022182890A5 (https=) | ||
| JPWO2023196996A5 (https=) | ||
| CN113265004A (zh) | 一种高表达的gpc3-car结构及应用 | |
| Fenning et al. | T cell lines recognizing the 70‐kD protein of U1 small nuclear ribonucleoprotein (U1snRNP) | |
| Chen et al. | Common conformational effects of p53 mutations | |
| Lidqvist et al. | Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodies |